Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-06-01
|
| Series: | Infectious Agents and Cancer |